REGISTERED NUMBER: 01163795 (England and Wales)

Unaudited Financial Statements

for the Period

1 March 2025 to 25 November 2025

for

Clevechem Limited

Page

Company Information

1

Balance Sheet

2

Notes to the Financial Statements

3

DIRECTORS:

N Gupta

N D S Sangha

REGISTERED OFFICE:

Redcar Primary Care Hospital

West Dyke Road

Redcar

Cleveland

TS10 4NW

REGISTERED NUMBER:

01163795 (England and Wales)

ACCOUNTANTS:

Anderson Barrowcliff Limited

Chartered Accountants

3 Kingfisher Court

Bowesfield Park

Stockton on Tees

TS18 3EX

FIXED ASSETS

Tangible assets

4

349,491

383,823

CURRENT ASSETS

Stocks

5

104,123

84,238

Debtors

6

241,499

194,991

Cash at bank and in hand

208,545

72,700

554,167

351,929

CREDITORS

Amounts falling due within one year

7

358,228

291,511

NET CURRENT ASSETS

195,939

60,418

TOTAL ASSETS LESS CURRENT LIABILITIES

545,430

444,241

CAPITAL AND RESERVES

Called up share capital

8

500

500

Retained earnings

544,930

443,741

SHAREHOLDERS' FUNDS

545,430

444,241

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the period ended 25 November 2025.

The members have not required the company to obtain an audit of its financial statements for the period ended 25 November 2025 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:

(a)	ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and

(b)

preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 11 August 2026 and were signed on its behalf by:

N D S Sangha - Director

1.	STATUTORY INFORMATION

Clevechem Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

2.	ACCOUNTING POLICIES

Basis of preparing the financial statements

These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

The financial statements are presented in sterling which is the functional currency of the company and rounded to the nearest £1.

Turnover

Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Tangible fixed assets

Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.

Long leasehold

-

over the period of the lease

Fixtures and fittings

-

20% on cost

Computer equipment

-

25% on cost

Stocks

Stocks are valued at the lower of cost and net realisable value, after making due allowance for obsolete and slow moving items.

Taxation

Taxation for the period comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Deferred tax

Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the period end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Hire purchase and leasing commitments

Rentals paid under operating leases are charged to profit or loss on a straight line basis over the period of the lease.

Pension costs and other post-retirement benefits

The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate.

Impairment

Assets not measured at fair value are reviewed for any indication that the asset may be impaired at each balance sheet date. If such indication exists, the recoverable amount of the asset, or the asset's cash generating unit, is estimated and compared to the carrying amount. Where the carrying amount exceeds its recoverable amount, an impairment loss is recognised in profit and loss unless the asset is carried at a revalued amount where the impairment loss is a revaluation decrease,

3.	EMPLOYEES AND DIRECTORS

The average number of employees during the period was 17 (2025 - 15 ) .

4.	TANGIBLE FIXED ASSETS

Fixtures

Long

and

Computer

leasehold

fittings

equipment

Totals

£

£

£

£

COST

At 1 March 2025

807,660

110,190

5,470

923,320

Disposals

-

-

(5,470

)

(5,470

)

At 25 November 2025

807,660

110,190

-

917,850

DEPRECIATION

At 1 March 2025

432,083

107,300

114

539,497

Charge for period

28,268

708

-

28,976

Eliminated on disposal

-

-

(114

)

(114

)

At 25 November 2025

460,351

108,008

-

568,359

NET BOOK VALUE

At 25 November 2025

347,309

2,182

-

349,491

At 28 February 2025

375,577

2,890

5,356

383,823

5.

STOCKS

2025

2025

£

£

Stocks

104,123

84,238

6.

DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR

2025

2025

£

£

Trade debtors

221,691

157,907

Amounts owed by group undertakings

2,430

-

VAT

537

27,954

Prepayments

16,841

9,130

241,499

194,991

7.

CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR

2025

2025

£

£

Trade creditors

198,143

216,506

Other creditors

276

276

Amounts owed to group undertakings

10,652

61,254

Taxation

1,574

-

Social security and other taxes

-

4,881

Accrued expenses

147,583

8,594

358,228

291,511

8.	CALLED UP SHARE CAPITAL

Allotted, issued and fully paid:

Number:

Class:

Nominal

2025

2025

value:

£

£

10,000

Ordinary

0.05

500

500

9.	OTHER FINANCIAL COMMITMENTS

Amounts not provided for in the statement of financial position

The total amount of financial commitments not included in the statement of financial position is £616,025 (28 February 2025 - £672,785)

10.	PARENT AND ULTIMATE PARENT UNDERTAKING

The company's parent company is Coopers Healthcare Group Limited, who's registered office is 4 Hadrian Way, Ingleby Barwick, Stockton-on-Tees, TS17 5LN.